跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,892 条关于
“ExpreS2ion Biotechnologies”
全部
1,892
临床试验
1,476
药物
97
机构
36
资讯
283
去年
ExpreS2ion's ES2B-C001 HER2-Targeting Vaccine Approved for Phase I Trial in Breast Cancer
去年
ExpreS2ion Biotech Advances to Clinical Phase with HER2 Breast Cancer Vaccine, Reports Strong Q4 2024 Progress
7个月前
ExpreS2ion Biotech Reports Promising Immune Response Data from HER2-Targeting Cancer Vaccine Phase I Trial
去年
ExpreS2ion Amends Clinical Trial Protocol to Test Breast Cancer Vaccine in Combination with Antibody-Drug Conjugates
去年
Momentum Biotechnologies Acquires OmicScouts to Expand Mass Spectrometry-Based Drug Discovery Platform
去年
CollPlant Advances Regenerative Breast Implant Technology with Promising Preclinical Results
去年
Argenx Expands Partnership with Fujifilm Biotechnologies to Manufacture Efgartigimod in the U.S.
去年
Adverum's Ixo-vec Shows Promise in Wet AMD Phase 2 Trial, Phase 3 Planned for 2025
去年
Adaptive Biotechnologies Reports Strong MRD Business Growth in 2024 Financial Results
11个月前
POP Biotechnologies Secures $2.46M NIH Grant for Novel Dual-Target Alzheimer's Immunotherapy
第 1 页,共 29 页
上一页
下一页